中华耳鼻咽喉头颈外科杂志
中華耳鼻嚥喉頭頸外科雜誌
중화이비인후두경외과잡지
CHINESE JOURNAL OF OTORHINOLARYNGOLOGY HEAD AND NECK SURGERY
2011年
10期
807-813
,共7页
吴文灿%余波%王明玲%黄玲%涂云海%陈犇%瞿佳%王勤美
吳文燦%餘波%王明玲%黃玲%塗雲海%陳犇%瞿佳%王勤美
오문찬%여파%왕명령%황령%도운해%진분%구가%왕근미
Graves眼病%减压术,外科%内窥镜检查%脂肪切除术%眼眶%视神经疾病
Graves眼病%減壓術,外科%內窺鏡檢查%脂肪切除術%眼眶%視神經疾病
Graves안병%감압술,외과%내규경검사%지방절제술%안광%시신경질병
Graves ophthalmopathy%Decompression,surgical%Endoscopy%Lipectomy%Orbit%Optic nerve diseases
目的 探讨内镜下经筛径路眶内侧壁减压术联合内镜下经筛径路眶肌锥内脂肪减压术治疗Graves眼病(Graves' ophthalmopathy,GO)的可行性,并分析其疗效.方法 对2006年10月至2011年5月因并发眶尖拥挤视神经病变而接受眶减压手术的29例GO患者进行回顾性分析.所有患者术前确诊为非组织活动期,均因视力下降、视野缺损或色觉障碍,同时合并眼球突出而接受内镜下经筛径路眶内侧壁减压术联合肌锥内眶脂肪减压术,术后定期随访.根据术后9个月视力、色觉改善程度,以及眼球突出度矫正度、复视等并发症判断疗效.结果 共收集资料齐全的GO患者29例(45眼).术后9个月,44眼(97.8%)视力明显改善,视力从术前((x)±s,下同)的-0.65±0.30提高至-0.24±0.22,视力平均提高达0.55 ±0.17,手术前后比较差异有统计学意义(t=- 13.012,p<0.001);29眼术前色觉障碍者,23眼(79.3%)术后明显改善;术后双眼眼球对称度达100%,手术前后比较,平均眼球突出矫正度达(7.07±1.59) mm(4~11 mm).术后所有病例双眼眼球突出度相差<2 mm,除1例术后复视加重外,术后无一例新发复视、视力下降、眶内出血等并发症发生.结论内镜下经筛径路眶内侧壁减压术联合肌锥内眶脂肪减压术在实现眶尖部减压的同时可以达到有效矫正眼球突出度的效果,且具有微创,无颜面部瘢痕,术后复视、眼球移位等发生率极低的优点,该术式是治疗GO并发眶尖拥挤视神经病变患者的安全有效的手段之一.
目的 探討內鏡下經篩徑路眶內側壁減壓術聯閤內鏡下經篩徑路眶肌錐內脂肪減壓術治療Graves眼病(Graves' ophthalmopathy,GO)的可行性,併分析其療效.方法 對2006年10月至2011年5月因併髮眶尖擁擠視神經病變而接受眶減壓手術的29例GO患者進行迴顧性分析.所有患者術前確診為非組織活動期,均因視力下降、視野缺損或色覺障礙,同時閤併眼毬突齣而接受內鏡下經篩徑路眶內側壁減壓術聯閤肌錐內眶脂肪減壓術,術後定期隨訪.根據術後9箇月視力、色覺改善程度,以及眼毬突齣度矯正度、複視等併髮癥判斷療效.結果 共收集資料齊全的GO患者29例(45眼).術後9箇月,44眼(97.8%)視力明顯改善,視力從術前((x)±s,下同)的-0.65±0.30提高至-0.24±0.22,視力平均提高達0.55 ±0.17,手術前後比較差異有統計學意義(t=- 13.012,p<0.001);29眼術前色覺障礙者,23眼(79.3%)術後明顯改善;術後雙眼眼毬對稱度達100%,手術前後比較,平均眼毬突齣矯正度達(7.07±1.59) mm(4~11 mm).術後所有病例雙眼眼毬突齣度相差<2 mm,除1例術後複視加重外,術後無一例新髮複視、視力下降、眶內齣血等併髮癥髮生.結論內鏡下經篩徑路眶內側壁減壓術聯閤肌錐內眶脂肪減壓術在實現眶尖部減壓的同時可以達到有效矯正眼毬突齣度的效果,且具有微創,無顏麵部瘢痕,術後複視、眼毬移位等髮生率極低的優點,該術式是治療GO併髮眶尖擁擠視神經病變患者的安全有效的手段之一.
목적 탐토내경하경사경로광내측벽감압술연합내경하경사경로광기추내지방감압술치료Graves안병(Graves' ophthalmopathy,GO)적가행성,병분석기료효.방법 대2006년10월지2011년5월인병발광첨옹제시신경병변이접수광감압수술적29례GO환자진행회고성분석.소유환자술전학진위비조직활동기,균인시력하강、시야결손혹색각장애,동시합병안구돌출이접수내경하경사경로광내측벽감압술연합기추내광지방감압술,술후정기수방.근거술후9개월시력、색각개선정도,이급안구돌출도교정도、복시등병발증판단료효.결과 공수집자료제전적GO환자29례(45안).술후9개월,44안(97.8%)시력명현개선,시력종술전((x)±s,하동)적-0.65±0.30제고지-0.24±0.22,시력평균제고체0.55 ±0.17,수술전후비교차이유통계학의의(t=- 13.012,p<0.001);29안술전색각장애자,23안(79.3%)술후명현개선;술후쌍안안구대칭도체100%,수술전후비교,평균안구돌출교정도체(7.07±1.59) mm(4~11 mm).술후소유병례쌍안안구돌출도상차<2 mm,제1례술후복시가중외,술후무일례신발복시、시력하강、광내출혈등병발증발생.결론내경하경사경로광내측벽감압술연합기추내광지방감압술재실현광첨부감압적동시가이체도유효교정안구돌출도적효과,차구유미창,무안면부반흔,술후복시、안구이위등발생솔겁저적우점,해술식시치료GO병발광첨옹제시신경병변환자적안전유효적수단지일.
Objective To present a new mini-invasive surgery for compressive optic neuropathy (CON) in Graves' ophthalmopathy (GO) by adequately decompressing the orbital apex and correcting proptosis,and to analyze its results.Methods A retrospective chart was reviewed in 29 patients receiving orbital decompression for the treatment of CON secondary to GO from October 2006 to May 2011.All patients diagnosed CON were in stable and inactive phase of GO at least for 6 months.All patients received endoscopic transethmoid medial orbital wall decompression to reduce the compression on the orbital apex.In the meanwhile,an endoscopic transethmoid intraconal fat-removal orbital decompression was performed to remove parts of intraconal fat with a special aspiration/cutting instrument to further reduce the proptosis.All patients were followed up periodically.Results of improvement of visual acuity ( VA),color vision,and amount of proptosis reduction and incidence of induced diplopia 9 months after surgery was recorded for analysis its feasibility.Results Forty-five orbits of 29 patients were included in the study.At the 9 months review,44 of 45 eyes (97.8%) improved their VA from -0.65 ±0.30 (x ±s) preoperatively to -0.24 ± 0.22,with a mean improvement of 0.55 ± 0.17 ( t =- 13.01 2,P < 0.001 ),23 of 29 eyes ( 79.3% ) had improved color vision ( P < 0.001 ),and the mean reduction in proptosis was ( 7.07 ± 1.59 ) mm ( range 4- 11 mm).Postoperative symmetry to within 2 mm were achieved in all patients.Except 1 patient complaining of deterioration in diplopia following surgery,no patients presented new on-set diplopia postoperatively.Conclusion The endoscopic transethmoid medial orbital wall decompression combined with the endoscopic transethmoid intraconal fat-removal orbital decompression is an effective treatment with minimal morbidity for both visional recovery and improvement of proptosis for CON in GO.